Placemark Investments’s Novo Nordisk NVO Stock Holding History

Placemark Investments’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	$10.2M	Sell	480,100 -2,518	-0.5%	-$56.2K	0.18%	131
2014 Q3	$11.5M	Buy	482,618 +39,594	+9%	+$911K	0.21%	111
2014 Q2	$10.2M	Buy	443,024 +22,740	+5%	+$502K	0.18%	120
2014 Q1	$9.59M	Sell	420,284 -1,187,116	-74%	-$25.3M	0.18%	127
2013 Q4	$29.7M	Buy	1,607,400 +666,750	+71%	+$11.6M	0.49%	32
2013 Q3	$15.9M	Buy	940,650 +147,490	+19%	+$2.48M	0.3%	64
2013 Q2	$12.3M	Buy	+793,160	New	+$13.2M	0.26%	91

Other funds holding NVO

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Placemark Investments's NVO Position: Q4 2014 in Review

Placemark Investments reduced its Novo Nordisk (NVO) stake by 0.52% in Q4 2014, selling an estimated $56.2K and leaving 480,100 shares worth $10.2M. The position accounts for 0.18% of the portfolio, ranked #131.

Placemark Investments first reported a position in NVO in Q2 2013 and has held it in 7 quarters since. The position peaked at $29.7M in Q4 2013. 500 funds tracked by Wall St. Rank hold NVO as of Q4 2014.

Placemark Investments held 480,100 shares of Novo Nordisk worth $10.2M as of Q4 2014.
Placemark Investments sold 2,518 Novo Nordisk shares in Q4 2014, an estimated $56.2K.
Novo Nordisk made up 0.18% of Placemark Investments's portfolio in Q4 2014, its #131 holding.
Placemark Investments first reported a position in Novo Nordisk in Q2 2013 and has held it in 7 quarters since.
Placemark Investments's Novo Nordisk position peaked at $29.7M in Q4 2013.
500 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2014.

Based on Placemark Investments's 13F filing for Q4 2014, filed 17 Feb 2015.